Rapid Discontinuation of Steroids in Living Donor Kidney Transplantation: A Pilot Study

American Journal of Transplantation

Volumn 1, Issue 3, 2001, Pages 278-283

  Matas, Arthur J ^a   Ramcharan, Thiagarajan ^a   Paraskevas, Steven ^a   Gillingham, Kristen J ^a   Dunn, David L ^a   Gruessner, Rainer W G ^a   Humar, Abhinav ^a   Kandaswamy, Raja ^a   Najarian, John S ^a   Payne, William D ^a   Sutherland, David E R ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Kidney transplant; Steroid discontinuation

Indexed keywords

AZATHIOPRINE; DRUG DERIVATIVE; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; STEROID;

ARTICLE; CHEMICALLY INDUCED DISORDER; DRUG ADMINISTRATION; DRUG COMBINATION; HUMAN; IMMUNOLOGY; KIDNEY TRANSPLANTATION; LIVING DONOR; NUCLEAR FAMILY; PILOT STUDY; POSTOPERATIVE COMPLICATION; TIME;

AZATHIOPRINE; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LIVING DONORS; MYCOPHENOLIC ACID; NUCLEAR FAMILY; PILOT PROJECTS; POSTOPERATIVE COMPLICATIONS; PREDNISONE; STEROIDS; TIME FACTORS;

EID: 18044399260     PISSN: 16006135     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-6143.2001.001003278.x     Document Type: Article

References (22)

1. Starzl TE, Marchioro TL, Waddel WR. The reversal of rejection in human renal homograft with subsequent development of homograft tolerance. Surg Gynecol Obstet 1963; 117: 385-395.
2. Hricik DE, OToole MA, Schulak JA, Herson J. Steroid-free immuno-suppression in cyclosporine-treated renal transplant recipients: a meta-analysis. J Am Soc Nephrol 1993; 4: 1300-1305.
3. Kasiske BL, Chakkera HA, Louis TA, Ma JZ. A meta-analysis of immunosuppression withdrawal trials in renal transplantation. J Am Soc Nephrol 2000; 11: 1910-1917.
4. Sinclair NRS for Canadian Multicentre Transplant Study Group. Low-dose steroid therapy in cyclosporine-treated renal transplant recipients with well-functioning grafts. Can Med Assoc J 1992; 147: 645-657.
5. Vanrenterghem Y, Lebranchu Y, Hené R, Oppenheimer F, Ekberg H for Steroid Dosing Study Group. Prednisone withdrawal in kidney transplant recipients on cyclosporine and mycophenolate mofetil - a prospective randomized study. Transplantation 2000; 70: 1352-1370.
6. Steroid Withdrawal Study Group. Prednisone withdrawal in kidney transplant recipients on cyclosporine and mycophenolate mofetil - a prospective randomized study. Transplantation 1999; 68: 1865-1874.
7. Hricik DE, Seliga RM, Fleming-Brooks S, Bartucci MR, Schulak JA. Determinants of long-term allograft function following steroid withdrawal in renal transplant recipients. Clin Transpl 1995; 9: 419-423.
8. Almawi WY, Hess DA, Chudzik DM, Rieder MJ. Pretreatment with glucocorticoids enhances T-cell effector function: possible implication for immune rebound accompanying glucocorticoid withdrawal. Cell Transplant 1999; 8: 637-647.
9. Troppmann C, Gillingham KJ, Benedetti E et al. Delayed graft function, acute rejection, and outcome after cadaver renal transplantation. The multivariate analysis. Transplantation 1995; 59: 962-968.
10. Humar A, Sutherland DE, Ramcharan T, Gruessner RW, Gruessner AC, Kandaswamy R. Optimal timing for a pancreas transplant after a successful kidney transplant. Transplantation 2000; 70: 1247-50.
11. Johnson EM, Canafax DM, Gillingham KJ et al. Effect of early cyclosporine levels on kidney allograft rejection. Clin Transplant 1997; 11: 552-557.
12. Matas AJ, Payne WD, Sutherland DER et al. 2,500 living donor kidney transplants - a single institution experience. Ann Surg 2001, in press.
13. Matas AJ. Risk factors for chronic rejection - a clinical perspective. Transpl Immunol 1998; 6: 1-11.
14. Birkeland SA. Steroid-free immunosuppression after kidney transplantation with antithyrnocyte globulin induction and cyclosporine and mycophenolate mofetil maintenance therapy. Transplantation 1998; 66: 1207-1210.
15. Cantarovich D, Giral-Classe M, Hourmant M et al. Low incidence of kidney rejection after simultaneous kidney-pancreas transplantation after antithymocyte globulin induction and in the absence of corticosteroids: results of a prospective pilot study in 28 consecutive cases. Transplantation 2000; 69: 1505-1508.
16. Vincenti F, Monaco A, Grinyo J et al. Rapid steroid withdrawal versus standard steroid treatment in patients treated with Simulect®, Neoral®, and CellCept® for the prevention of acute rejection in renal transplantation: a multicenter, randomized trial. Transplantation 2000; 69 (Suppl): S133.
17. Kaufman DB, Leventhal JR, Fryer JP, Abecassis MI, Stuart FP. Kidney transplantation without prednisone. Transplantation 2000; 69 (Suppl): S133.
18. Landsberg DN, Cole EH, Russell D et al. Renal transplantation without steroids - one year results of a multicentre Canadian pilot study. Transplantation 2000; 69 (Suppl): S134.
19. Buell JF, Kulkarni S, Grewal HP et al. Early corticosteroid cessation at one week following kidney transplant under tacrolimus and mycophenolate mofetil (MMF) immunosuppression, three-year follow-up. Transplantation 2000; 69 (Suppl): S134.
20. Julian BA, Laskow DA, Dubovsky J, Dubovsky EV, Curtis JJ, Quarles LD. Rapid loss of vertebral mineral density after renal transplantation. N Engl J Med 1991; 325: 544-550.
21. Shane E, Epstein S. Transplantation osteoporosis. Transplant Reviews 2001; 15: 11-32.
22. McKenzie R, Reynolds JC, O'Fallon A, Dale J, Deloria M, Blackwelder W, Straus SE. Decreased bone mineral density during low dose glucocorticoid administration in a randomized, placebo controlled trial. J Rheumatol 2000; 27: 2222-2226.